לטרוזול אינובמד 2.5 מ"ג
Land: Israel
Språk: hebraisk
Kilde: Ministry of Health
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
LETROZOLE 2.5 MG
Tilgjengelig fra:
INOVAMED LTD
ATC-kode:
L02BG04
Legemiddelform:
FILM COATED TABLETS
Administreringsrute:
PER OS
Produsert av:
SYNTHON B.V., NETHERLANDS
Terapeutisk gruppe:
LETROZOLE
Indikasjoner:
For first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. For the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy.Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Autorisasjon dato:
2011-01-01
